MAIDA ANTHONY E III 4
4 · INNOVATE BIOPHARMACEUTICALS, INC. · Filed May 4, 2020
Insider Transaction Report
Form 4
MAIDA ANTHONY E III
Director
Transactions
- Award
Stock Option (Right to Buy)
2020-04-24+25,000→ 25,000 totalExercise: $0.60From: 2020-04-24Exp: 2030-04-24→ Common stock (25,000 underlying)
Footnotes (1)
- [F1]This option vested in full on the grant date, 4/24/2020.